Skip to main content
OpenTrials
Completed

NCT Number: NCT06113185

Turkish Pain Behaviour Scale in Adults With Chronic Nonspecific Low Back Pain

The aim of this study was to translate and culturally adapt the Pain Behaviour Scale (PaBS) into Turkish and to evaluate its psychometric properties in adults with chronic nonspecific low back pain. Specifically, the study examined interrater reliability, intrarater reliability, agreement, measurement error, and construct validity of the Turkish version of the PaBS during standardized functional performance tasks.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Acıbadem Health Group

Istanbul, None Selected, 34752, Turkey (Türkiye)

About this study

The Pain Behaviour Scale (PaBS) is a clinician-rated observational measure designed to assess the presence and severity of pain behaviors during functional movement in individuals with chronic low back pain. Before its use in Turkish-speaking populations, translation, cross-cultural adaptation, and psychometric evaluation were required.

In this cross-cultural adaptation and psychometric validation study, the PaBS was translated into Turkish, back-translated, reviewed by an expert panel, and pilot-tested before the main psychometric evaluation. The prefinal Turkish version was pilot-tested in 20 adults with chronic nonspecific low back pain, and the pilot data were not included in the main analyses.

The main study included adults aged 18-55 years with chronic nonspecific low back pain lasting more than three months. Participants completed self-reported measures of pain, disability, and fear-avoidance beliefs and performed standardized physical performance tests. During the first testing session, two independent physiotherapists simultaneously rated pain behaviors using the Turkish PaBS. One rater repeated the PaBS assessment approximately one week later. The psychometric evaluation included interrater and intrarater reliability, agreement, measurement error, and construct validity.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18-55 years
  • Chronic nonspecific low back pain lasting longer than 3 months
  • Sufficient cognitive and language ability to understand study instructions, complete questionnaires, and provide informed consent

Exclusion criteria

  • Clinical features suggesting serious spinal pathology, including malignancy, infection, fracture, or cauda equina syndrome
  • Spinal stenosis
  • Signs of radiculopathy, including radiating leg pain, weakness, numbness, or tingling
  • Previous fracture or surgery in the relevant spinal region
  • History of rheumatic disease
  • Pregnancy

Treatment and study plan

Turkish Pain Behaviour Scale Assessment

Other

Participants completed self-report measures of pain intensity and characteristics, disability, and fear-avoidance beliefs and performed five standardized physical performance tests: repeated trunk flexion, repeated sit-to-stand, Timed Up and Go, loaded reach, and 50-foot walk. During the first testing session, two independent physiotherapists simultaneously assessed the presence and severity of pain behaviors using the Turkish Pain Behaviour Scale (PaBS). For intrarater reliability, one rater repeated the PaBS assessment during a second testing session approximately one week later. No therapeutic intervention was administered as part of the study assessments.

Primary outcomes

  1. Turkish Pain Behaviour Scale (PaBS)

    Time frame: Baseline and approximately 1 week

    The Turkish Pain Behaviour Scale (PaBS) is a clinician-rated observational measure used to assess the presence and severity of pain behaviors during five standardized physical performance tests. Observed behaviors include sighing, breath-holding, grimacing, guarding, rubbing, and antalgic gait. For each physical performance test, the presence or absence of individual behaviors is recorded and the overall severity of observed pain behavior is rated from 0 to 3. The total PaBS severity score ranges from 0 to 15, with higher scores indicating greater severity of observed pain behaviors. Interrater reliability was evaluated using ratings from two independent raters during the first testing session, and intrarater reliability was evaluated using ratings from the same rater across two testing sessions.

Secondary outcomes

  1. Oswestry Disability Index (ODI)

    Time frame: Baseline and approximately 1 week

    Low back pain-related disability was assessed using the Oswestry Disability Index (ODI). The total score is expressed as a percentage, with higher scores indicating greater disability.

  2. Fear-Avoidance Beliefs Questionnaire (FABQ)

    Time frame: Baseline and approximately 1 week

    Fear-avoidance beliefs were assessed using the Fear-Avoidance Beliefs Questionnaire (FABQ), including the physical activity and work subscales and the total score. Higher scores indicate greater fear-avoidance beliefs.

  3. Short-Form McGill Pain Questionnaire (SF-MPQ)

    Time frame: Baseline and approximately 1 week

    Pain characteristics were assessed using the Short-Form McGill Pain Questionnaire (SF-MPQ), including sensory and affective pain descriptors. Sensory, affective, and total scores were recorded, with higher scores indicating greater pain-related symptom burden.

  4. MPQ-VAS Pain Intensity

    Time frame: Baseline and approximately 1 week

    Pain intensity was assessed using the visual analog scale component of the Short-Form McGill Pain Questionnaire (MPQ-VAS). Higher scores indicate greater pain intensity.

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Acibadem University

Other

Registry information

Official study title

Reliability and Validity of the Turkish Pain Behaviour Scale in Adults With Chronic Nonspecific Low Back Pain

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Nov 2, 2023
Registry last updated
Sep 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.